Sleep Disorders Trial, Recruiting (NCT06769607)

Sleep Disorders Trial, Recruiting NCT06769607 Sponsor: ResMed Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06769607 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to sign a written consent form to take part in the study
You can read and understand English
You are 18 years of age or older
You currently use a ResMed AirSense 10 or 11 machine
Your device is set to "AutoSet" (automatic pressure adjustment) mode
You have been using a PAP (pressurised air) breathing therapy device to treat sleep apnoea for more than 3 months
You are able to take part in the study for up to 8 weeks

Who may not be able to join:

You use a Bilevel flow generator (a type of breathing device that delivers two different pressure levels)
You use a standard CPAP machine or an AutoSet for Her device
You are pregnant or think you may be pregnant
You have a pre-existing lung disease or condition that could put you at risk of a collapsed lung — for example, COPD, lung cancer, lung scarring, a lung injury, or a lung infection or pneumonia within the last 2 years (confirm with trial site)
The researcher leading the study considers you unsuitable for participation for any reason (confirm with trial site)
You are currently taking part in another medical clinical study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 288841722

Australian sites

ResMed Ltd, Bella Vista, New South Wales
+61 288841722

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06769607

Sponsor: ResMed

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +61 288841722

More information: https://clinicaltrials.gov/study/NCT06769607

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to sign a written consent form to take part in the study
You can read and understand English
You are 18 years of age or older
You currently use a ResMed AirSense 10 or 11 machine
Your device is set to "AutoSet" (automatic pressure adjustment) mode
You have been using a PAP (pressurised air) breathing therapy device to treat sleep apnoea for more than 3 months
You are able to take part in the study for up to 8 weeks

Who may not be able to join:

You use a Bilevel flow generator (a type of breathing device that delivers two different pressure levels)
You use a standard CPAP machine or an AutoSet for Her device
You are pregnant or think you may be pregnant
You have a pre-existing lung disease or condition that could put you at risk of a collapsed lung — for example, COPD, lung cancer, lung scarring, a lung injury, or a lung infection or pneumonia within the last 2 years (confirm with trial site)
The researcher leading the study considers you unsuitable for participation for any reason (confirm with trial site)
You are currently taking part in another medical clinical study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ResMed

Registry

ClinicalTrials.gov

Start date

10 April 2025

Est. completion

1 December 2025

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Comparison of the algorithm efficacy (AHI) to a clinically relevant data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov